Oncotest GmbH

Compound testing

Oncotest was founded 1992 and is located in Freiburg, Germany. Cooperations include many pharmaceutical and biotech companies and institutions such as the European Organisation for Research and Therapy of Cancer and the National Cancer Institute of the USA. The company’s three in vitro and in vivo screens use permanent tumour cell lines (monolayer assay) or human xenografts (clonogenic assay and in vivo studies).

Heinz-Herbert Fiebig (CEO)

Am Flughafen 12-14
79108 Freiburg
Germany
Phone: +49-761-51559-0
Fax: +49-761-51559-55